Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy [NA]

View source ↗

Summary

This clinical trial aims to assess the safety of Shengbai Oral Formula and its ability to alleviate adverse effects in cancer patients undergoing chemotherapy. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shengbai Oral Formula

Snippet

Sponsor: Sutter Health | Conditions: Cancer | NA | Status: RECRUITING